Zealand gains $100M in funding from Royalty Pharma (RPRX:NASDAQ)
Finance Desk
Hailshadow/iStock via Getty Images
Royalty Pharma (RPRX) will provide $100M in funding to Zealand Pharma (ZLDPF) in exchange for a royalty for rusfertide (PTG-300), its candidate from the rare blood disease polycythemia vera.
Terms call for Royalty to have rights to a 1% royalty on
